DrugApr 24, 2024
Vancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL recall — FDA D-0442-2024
Superpotent Drug: Due to overfilling of drug powder
Class IFDA: TerminatedAmneal Pharmaceuticals of New York, LLC
Recall history in this database
Classification mix: Class III: 1, Class II: 1, Class I: 1.
DrugFeb 14, 2024
Amneal Pharmaceuticals of New York Phenoxybenzamine Hydrochloride Capsules, USP 10mg recall — FDA D-0319-2024
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Class IIFDA: TerminatedAmneal Pharmaceuticals of New York, LLC
DrugMay 31, 2023
Amneal Pharmaceuticals of New York Methylprednisolone Acetate Injectable Suspension, USP 80 recall — FDA D-0756-2023
Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number…
Class IIIFDA: TerminatedAmneal Pharmaceuticals of New York, LLC
Understanding this recall history
This page summarizes recall records in which the official source identifies Amneal Pharmaceuticals of New York, LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.